Genetic bowel cancer blood test developed by Australian researchers

The test co-developed by an Australian biotechnology company and the CSIRO, detects the presence of two genes, BCAT1 and IKZF, which are known to hypermethylate in colorectal cancer tumours.

Using plasma samples from 2187 Australian and Dutch volunteers, researchers from Flinders University in Adelaide found that the test identified 85 out of 100 colorectal cancer cases (65%).

# Tags